VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
JNJ
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
JNJJohnson & Johnson
$254.66$613.0B
Overview & Verdict
OverviewShould I Buy?
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksJNJQuarterly Financials

Johnson & Johnson (JNJ) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Johnson & Johnson (JNJ) quarterly income statement — complete revenue, gross profit & net income history

JNJ Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23
Sales/Revenue24.06B24.56B23.99B23.74B21.89B22.52B22.47B22.45B21.38B21.39B21.35B21.52B
Revenue Growth %9.91%9.08%6.77%5.77%2.39%5.26%5.25%4.31%2.34%-9.75%6.78%-10.41%
Cost of Goods Sold6.86B7.97B7.3B7.63B7.36B7.13B6.96B6.87B6.51B6.8B6.61B6.46B
COGS % of Revenue28.51%32.44%30.44%32.13%33.6%31.65%30.99%30.6%30.45%31.77%30.94%30.03%
Gross Profit17.2B16.6B16.69B16.11B14.54B15.39B15.51B15.58B14.87B14.6B14.74B15.06B
Gross Margin %71.49%67.56%69.56%67.87%66.4%68.35%69.01%69.4%69.55%68.23%69.06%69.97%
Gross Profit Growth %18.35%7.82%7.62%3.45%-2.26%5.45%5.17%3.46%4.68%-8.43%6.66%-6.48%
Operating Expenses10.81B11.01B9.59B9.3B8.24B11.55B10.23B8.92B8.6B9.99B8.55B8.7B
OpEx % of Revenue44.92%44.8%39.99%39.19%37.62%51.29%45.53%39.74%40.21%46.69%40.03%40.42%
Selling, General & Admin6.03B6.75B5.92B5.79B5.01B6.25B5.28B5.48B5.06B5.51B5.1B5B
SG&A % of Revenue25.08%27.49%24.68%24.38%22.89%27.77%23.49%24.42%23.65%25.75%23.89%23.22%
Research & Development3.53B4.25B3.67B3.52B3.23B5.3B4.95B3.44B3.54B4.48B3.45B3.7B
R&D % of Revenue14.66%17.31%15.3%14.81%14.73%23.53%22.04%15.32%16.56%20.94%16.14%17.21%
Other Operating Expenses1000K00000000000
Operating Income6.39B5.59B7.1B6.81B6.3B3.84B5.28B6.66B6.27B4.61B6.2B6.36B
Operating Margin %26.58%22.76%29.58%28.68%28.77%17.06%23.49%29.66%29.34%21.53%29.03%29.55%
Operating Income Growth %1.52%45.56%34.44%2.3%0.41%-16.63%-14.84%4.7%0.43%17.98%9.43%-1.76%
EBITDA8.4B7.6B8.87B8.75B8.07B5.74B7.12B8.44B8.09B6.45B8.03B8.29B
EBITDA Margin %34.91%30.95%36.98%36.87%36.87%25.48%31.7%37.6%37.82%30.15%37.6%38.53%
EBITDA Growth %4.06%32.51%24.55%3.72%-0.21%-11.05%-11.25%1.77%-0.47%13.62%9.23%0.92%
D&A (Non-Cash Add-back)2B2.01B1.78B1.94B1.77B1.9B1.85B1.78B1.81B1.84B1.83B1.93B
EBIT6.26B5.18B7.51B6.8B13.84B4.02B3.53B6.02B3.87B4.98B5.41B6.52B
Net Interest Income-43M23M-18M-48M128M144M99M125M209M212M182M109M
Interest Income229M237M227M260M332M281M292M395M364M363M374M326M
Interest Expense272M214M245M308M204M137M193M270M155M151M192M217M
Other Income/Expense-405M-625M397M-319M7.33B46M-1.94B-909M-2.56B219M-981M-52M
Pretax Income5.99B4.97B7.49B6.49B13.63B3.89B3.34B5.75B3.71B4.83B5.22B6.31B
Pretax Margin %24.89%20.22%31.23%27.34%62.26%17.26%14.85%25.61%17.37%22.56%24.43%29.3%
Income Tax755M-150M2.34B954M2.63B456M644M1.06B459M694M908M930M
Effective Tax Rate %12.6%-3.02%31.24%14.7%19.31%11.73%19.29%18.48%12.36%14.38%17.4%14.75%
Net Income5.24B5.12B5.15B5.54B11B3.43B2.69B4.69B3.25B4.05B26.03B5.14B
Net Margin %21.76%20.83%21.47%23.32%50.24%15.24%11.99%20.88%15.22%18.93%121.91%23.9%
Net Income Growth %-52.4%49.11%91.24%18.16%237.91%-15.26%-89.65%-8.9%4886.76%15.03%483.85%6.86%
Net Income (Continuing)5.24B5.12B5.15B5.54B11B3.43B2.69B4.69B3.25B4.13B4.31B5.38B
Discontinued Operations000000000-1000K1000K-1000K
Minority Interest000000000001.26B
EPS (Diluted)2.142.102.122.294.541.411.111.931.341.6710.211.96
EPS Growth %-52.86%48.94%90.99%18.65%238.81%-15.57%-89.13%-1.53%4566.67%25.56%507.74%8.89%
EPS (Basic)2.142.102.142.294.571.431.121.951.351.6810.321.98
Diluted Shares Outstanding2.45B2.44B2.43B2.42B2.42B2.43B2.43B2.42B2.43B2.43B2.55B2.63B
Basic Shares Outstanding2.45B2.43B2.43B2.42B2.41B2.41B2.41B2.41B2.41B2.41B2.52B2.6B
Dividend Payout Ratio59.81%61.2%60.79%56.51%27.18%86.97%110.8%63.7%88.14%70.76%11.03%60.11%